Congestive heart failure chronic pharmacotherapy: Revision history

View logs for this page

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

curprev 11:3811:38, 19 August 2022‎ Sara Zand talk contribs‎ 42,038 bytes +1‎ →‎Sodium-glucose co-transporter 2 inhibitors
curprev 11:3711:37, 19 August 2022‎ Sara Zand talk contribs‎ 42,037 bytes +3‎ →‎Angiotensin receptor-neprilysin inhibitor
curprev 11:3611:36, 19 August 2022‎ Sara Zand talk contribs‎ 42,034 bytes +51‎ →‎Overview

curprev 05:3605:36, 5 August 2022‎ Sara Zand talk contribs‎ 41,983 bytes +16‎ →‎Cardiac myosin activator

curprev 13:0113:01, 12 March 2022‎ Sara Zand talk contribs‎ 41,967 bytes −12‎ →‎Overview

curprev 16:1016:10, 20 February 2022‎ Sara Zand talk contribs‎ 34,808 bytes +1‎ →‎Overview
curprev 16:0516:05, 20 February 2022‎ Sara Zand talk contribs‎ 34,807 bytes +14‎ No edit summary

curprev 08:0608:06, 11 February 2022‎ Sara Zand talk contribs‎ 30,444 bytes +1‎ →‎Other medications in HFrEF in patients with NYHA 2-4
curprev 07:5907:59, 11 February 2022‎ Sara Zand talk contribs‎ 30,443 bytes −5‎ →‎Other medications in HFrEF in patients with NYHA 2-4
curprev 07:5707:57, 11 February 2022‎ Sara Zand talk contribs‎ 30,448 bytes +5,579‎ →‎Drugs recommended in all patients with heart failure with reduced ejection fraction
curprev 07:2207:22, 11 February 2022‎ Sara Zand talk contribs‎ 24,869 bytes +10‎ →‎Medications indicated in patients with New York Heart Association (NYHA class II–IV) heart failure with reduced ejection fraction (LVEF <_40%)

curprev 21:0521:05, 29 July 2020‎ WikiBot talk contribs‎ m 22,295 bytes −27‎ Bot: Removing from Primary care

curprev 18:2318:23, 28 October 2016‎ Mehdi Pahlavani talk contribs‎ m 22,322 bytes 0‎ Mehdi Pahlavani moved page Congestive heart failure chronic pharmacotherapy x to Congestive heart failure chronic pharmacotherapy over redirect
curprev 18:2318:23, 28 October 2016‎ Mehdi Pahlavani talk contribs‎ m 22,322 bytes 0‎ Mehdi Pahlavani moved page Congestive heart failure chronic pharmacotherapy to Congestive heart failure chronic pharmacotherapy x

curprev 00:2300:23, 13 May 2014‎ C Michael Gibson talk contribs‎ 22,322 bytes 0‎ →‎Aldosterone Antagonism: Fourth Step in the Management of Heart Failure
curprev 00:2200:22, 13 May 2014‎ C Michael Gibson talk contribs‎ 22,322 bytes +68‎ →‎ACE Inhibition and Angiotensin Receptor Blockade: Second Step in the Management of Heart Failure

curprev 19:5219:52, 8 May 2014‎ C Michael Gibson talk contribs‎ 22,254 bytes −2,020‎ →‎Cardiac Transplantation

curprev 14:2014:20, 6 May 2014‎ Rim Halaby talk contribs‎ 24,274 bytes −164‎ No edit summary
curprev 14:0814:08, 6 May 2014‎ C Michael Gibson talk contribs‎ 24,438 bytes +23‎ →‎ACE Inhibition and Angiotensin Receptor Blockade: Second Step in the Management of Heart Failure
curprev 14:0014:00, 6 May 2014‎ C Michael Gibson talk contribs‎ 24,415 bytes −260‎ →‎Cardiac Resynchronization Therapy

curprev 23:3823:38, 19 August 2013‎ Mahmoud Sakr talk contribs‎ 22,713 bytes +10‎ No edit summary

curprev 19:5919:59, 11 August 2013‎ Gerald Chi talk contribs‎ 22,703 bytes −125‎ No edit summary

curprev 21:1821:18, 26 July 2013‎ Mahmoud Sakr talk contribs‎ 22,828 bytes +249‎ No edit summary
curprev 21:1721:17, 26 July 2013‎ Mahmoud Sakr talk contribs‎ 22,579 bytes +249‎ No edit summary

curprev 00:0900:09, 1 May 2013‎ C Michael Gibson talk contribs‎ m 22,330 bytes 0‎ C Michael Gibson moved page Chronic Pharmacotherapy to Congestive heart failure chronic pharmacotherapy

curprev 01:2501:25, 30 April 2013‎ C Michael Gibson talk contribs‎ 22,330 bytes +20,620‎ →‎Overview
curprev 01:2301:23, 30 April 2013‎ C Michael Gibson talk contribs‎ 1,710 bytes −18,407‎ No edit summary

Retrieved from "https://www.wikidoc.org/index.php/Congestive_heart_failure_chronic_pharmacotherapy"

Cookies help us deliver our services. By using our services, you agree to our use of cookies.